Xiaobo Li
Impact in
- Cancer Research top 10%
- Cancer, Lipids, and Metabolism
- Pharmacology top 5%
- Drug-Induced Hepatotoxicity and Protection
Papers in
- Surgery 22
- Cholesterol and Lipid Metabolism 15
- Pancreatic function and diabetes 4
-
- Peroxisome Proliferator-Activated Receptors 6
- Epigenetics and DNA Methylation 5
- Co-authors
- Shunlin Ren (7 shared papers)William M. Pandak (6 shared papers)Dongke Xu (9 shared papers)Lianhua Yin (7 shared papers)Phillip B. Hylemon (4 shared papers)Ning Sun (9 shared papers)Xiaohong Lei (8 shared papers)Yanxia Ning (8 shared papers)
- Journals
- Biochemical and Biophysical Research Communications (4 papers)Journal of Lipid Research (3 papers)Lipids in Health and Disease (2 papers)International Journal of Biological Sciences (2 papers)eLife (2 papers)
- Partner nations
- ChinaUnited StatesMontenegro
In The Last Decade
Xiaobo Li
68 papers receiving 1.7k citations
Peers
Comparison fields: 5 of 118
- Cancer Research 238
- Pharmacology 109
- Biochemistry 84
- Surgery 395
- Oncology 237
Countries citing papers authored by Xiaobo Li
This map shows the geographic impact of Xiaobo Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaobo Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaobo Li more than expected).
Fields of papers citing papers by Xiaobo Li
This network shows the impact of papers produced by Xiaobo Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaobo Li. The network helps show where Xiaobo Li may publish in the future.
Co-authors
The 25 scholars most cited alongside Xiaobo Li, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 69 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2021 | 151 | |
| 2 | 2020 | 88 | |
| 3 | 2016 | 81 | |
| 4 | 2007 | 74 | |
| 5 | 2008 | 69 | |
| 6 | 2022 | 58 | |
| 7 | 2019 | 57 | |
| 8 | 2020 | 56 | |
| 9 | 2024 | 55 | |
| 10 | 2007 | 53 | |
| 11 | 2008 | 52 | |
| 12 | 2006 | 47 | |
| 13 | 2015 | 44 | |
| 14 | 2022 | 36 | |
| 15 | 2017 | 35 | |
| 16 | 2006 | 33 | |
| 17 | 2017 | 32 | |
| 18 | 2018 | 32 | |
| 19 | 2022 | 29 | |
| 20 | 2019 | 28 |
About Xiaobo Li
Xiaobo Li is a scholar working on Surgery, Molecular Biology, Oncology, Epidemiology and Pharmacology, having authored 69 papers that have together received 1.7k indexed citations. Recurring topics across this work include Cholesterol and Lipid Metabolism (15 papers), Drug Transport and Resistance Mechanisms (14 papers), Liver Disease Diagnosis and Treatment (12 papers), Drug-Induced Hepatotoxicity and Protection (7 papers), Peroxisome Proliferator-Activated Receptors (6 papers), Epigenetics and DNA Methylation (5 papers), Pancreatic function and diabetes (4 papers) and Pharmacogenetics and Drug Metabolism (3 papers). The work is most often cited by research in Cancer Research (238 citations), Pharmacology (109 citations), Biochemistry (84 citations), Surgery (395 citations) and Oncology (237 citations). Xiaobo Li has collaborated with scholars based in China, United States and Montenegro. Frequent co-authors include Shunlin Ren, William M. Pandak, Dongke Xu, Lianhua Yin, Phillip B. Hylemon, Ning Sun, Xiaohong Lei, Yanxia Ning, Yongjie Ma and Yufan Zheng. Their work appears in journals such as Biochemical and Biophysical Research Communications, Journal of Lipid Research, Lipids in Health and Disease, International Journal of Biological Sciences and eLife.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.